Cell loaded hydrogel containing Ag-doped bioactive glass-ceramic nanoparticles as skin substitute: Antibacterial properties, immune response, and scarless cutaneous wound regeneration.
Ag‐doped bioactive glass–ceramics
anti‐biofilm
hemocompatible
immunogenicity
skin substitute
wound healing
Journal
Bioengineering & translational medicine
ISSN: 2380-6761
Titre abrégé: Bioeng Transl Med
Pays: United States
ID NLM: 101689146
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
23
11
2021
revised:
21
05
2022
accepted:
16
07
2022
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
1
10
2022
Statut:
epublish
Résumé
An ideal tissue-engineered dermal substitute should possess angiogenesis potential to promote wound healing, antibacterial activity to relieve the bacterial burden on skin, as well as sufficient porosity for air and moisture exchange. In light of this, a glass-ceramic (GC) has been incorporated into chitosan and gelatin electrospun nanofibers (240-360 nm), which MEFs were loaded on it for healing acceleration. The GC was doped with silver to improve the antibacterial activity. The bioactive nanofibrous scaffolds demonstrated antibacterial and superior antibiofilm activities against Gram-negative and Gram-positive bacteria. The nanofibrous scaffolds were biocompatible, hemocompatible, and promoted cell attachment and proliferation. Nanofibrous skin substitutes with or without Ag-doped GC nanoparticles did not induce an inflammatory response and attenuated LPS-induced interleukin-6 release by dendritic cells. The rate of biodegradation of the nanocomposite was similar to the rate of skin regeneration under in vivo conditions. Histopathological evaluation of full-thickness excisional wounds in BALB/c mice treated with mouse embryonic fibroblasts-loaded nanofibrous scaffolds showed enhanced angiogenesis, and collagen synthesis as well as regeneration of the sebaceous glands and hair follicles in vivo.
Identifiants
pubmed: 36176609
doi: 10.1002/btm2.10386
pii: BTM210386
pmc: PMC9471996
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10386Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest associated with this work.
Références
Materials (Basel). 2020 Dec 11;13(24):
pubmed: 33322335
J Biomed Mater Res A. 2021 Jul;109(7):1275-1285
pubmed: 33058428
Biomaterials. 2021 Jan;268:120558
pubmed: 33307369
J Biomed Mater Res. 2001 Dec 15;57(4):532-40
pubmed: 11553883
J Nanostructure Chem. 2022;12(5):919-932
pubmed: 34580605
Mayo Clin Proc. 2013 Sep;88(9):1022-31
pubmed: 24001495
Biomed Mater. 2009 Jun;4(3):031001
pubmed: 19372619
Future Microbiol. 2014;9(5):593-601
pubmed: 24957087
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Sep-Oct;2(5):510-25
pubmed: 20607703
Cold Spring Harb Perspect Med. 2015 Jan 05;5(1):a023267
pubmed: 25561722
ANZ J Surg. 2008 Aug;78(8):654-9
pubmed: 18796021
Trends Biotechnol. 2018 Sep;36(9):907-922
pubmed: 29764691
Cytokine Growth Factor Rev. 2015 Oct;26(5):595-602
pubmed: 26187858
Biomed Mater. 2021 Mar 02;16(3):035001
pubmed: 33650546
J Dermatolog Treat. 2020 Sep;31(6):639-648
pubmed: 30265595
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:1137-46
pubmed: 27612811
Development. 2016 Jul 15;143(14):2522-35
pubmed: 27287810
Carbohydr Polym. 2018 Jun 1;189:379-398
pubmed: 29580422
J Mech Behav Biomed Mater. 2013 Apr;20:173-83
pubmed: 23466499
J Tissue Eng Regen Med. 2021 Feb;15(2):116-128
pubmed: 33175476
Heliyon. 2019 Aug 28;5(8):e02253
pubmed: 31517085
Int J Pharm. 2021 Mar 1;596:120213
pubmed: 33493599
Future Med Chem. 2015;7(4):493-512
pubmed: 25875875
ACS Appl Mater Interfaces. 2016 Jan 13;8(1):703-15
pubmed: 26684719
J Funct Biomater. 2018 Mar 19;9(1):
pubmed: 29562680
Prog Biomater. 2018 Sep;7(3):207-218
pubmed: 30141130
Carbohydr Polym. 2020 Aug 1;241:116364
pubmed: 32507198
J Biomed Mater Res B Appl Biomater. 2020 Nov;108(8):3084-3098
pubmed: 32459395
Nat Protoc. 2013 Feb;8(2):302-9
pubmed: 23329003
Regen Med. 2018 Jul 1;13(5):491-495
pubmed: 30062921
J Microbiol Methods. 2014 Oct;105:134-40
pubmed: 25086178
Adv Sci (Weinh). 2022 Jan;9(2):e2102678
pubmed: 34796680
Acta Biomater. 2017 Mar 1;50:41-55
pubmed: 28011142
J Biomed Mater Res A. 2016 Sep;104(9):2210-9
pubmed: 27087544
Biomater Sci. 2020 Apr 21;8(8):2143-2155
pubmed: 32248211
J Biomed Mater Res A. 2012 Feb;100(2):305-22
pubmed: 22052581
Small. 2021 Oct;17(41):e2101384
pubmed: 34313003
Healthcare (Basel). 2014 Sep 10;2(3):356-400
pubmed: 27429283
Adv Healthc Mater. 2021 Aug;10(16):e2100477
pubmed: 34174163
ACS Appl Mater Interfaces. 2018 May 23;10(20):16977-16991
pubmed: 29718653
Cytokine Growth Factor Rev. 2008 Feb;19(1):41-52
pubmed: 18258476